After a tough year for cannabis in 2020, 2021 brought along a rebound in development towards legalisation, record-breaking sales of medical and adult-use cannabis as well as a massive influx of capital raises and M&A activity.
This report finds combined global sales of CBD, medical and adult-use cannabis topped US$37.4 billion in 2021, and could rise to US$105 billion by 2026
Overall, the industry is poised for a very exciting 2022, with the spread of legalisation being followed by strong industry growth. Benefits will be felt across justice, public health and the global economy.
(Originally posted by Cannabis News)